The role of in vivo confocal microscopy in the diagnosis of eyelid margin tumors: 47 cases - 16/10/14
, Jean Luc Perrot, MD a, Nelly Campolmi, MD b, d, Bruno Labeille, MD a, Marine Espinasse, MD b, d, Damien Grivet, MD b, d, Gilles Thuret, PhD b, d, e, Philippe Gain, MD, PhD b, d, Catherine Douchet, MD c, Fabien Forest, MD c, Maher Haouas, MD b, Frédéric Cambazard, PhD aAbstract |
Background |
Handheld in vivo reflectance confocal microscopy (IVCM) is a new imaging method that allows noninvasive diagnosis of cutaneous tumors but to date it has not been used in the study of eyelid tumors.
Objective |
We sought to evaluate the suitability of IVCM for eyelid margin tumors.
Methods |
We prospectively evaluated the IVCM features of 47 eyelid margin lesions, clinically suspicious of malignancy; 35 of these were excised whereas the other 12, with no IVCM malignant features, were followed up for at least 1 year. Clinical, IVCM, and histologic diagnoses were compared.
Results |
IVCM showed sensitivity and specificity of 100% and 69.2%, respectively, for malignancy (basal cell carcinoma, squamous cell carcinoma, and melanoma). The follow-up of the 12 nonexcised lesions did not show any clinical progression.
Limitations |
The lesions showing neither clinical nor IVCM features for malignancies were not biopsied in view of the potential functional and aesthetic consequences of eyelid margin surgery.
Conclusion |
Used with a handheld dermatology-specific microscope, IVCM can play a role in the noninvasive diagnosis of eyelid margin lesions. Further studies are needed to better define diagnostic criteria of eyelid tumors and improve the specificity of this technique.
Le texte complet de cet article est disponible en PDF.Key words : basal cell carcinoma, eyelid, eyelid margin, in vivo, melanoma, mucosa, reflectance confocal microscopy, tumor
Abbreviations used : BCC, IVCM, SCC
Plan
| Funding sources: None. |
|
| Reprints not available from the authors. |
|
| Conflicts of interest: None declared. |
Vol 71 - N° 5
P. 912 - novembre 2014 Retour au numéro
Article précédent
- An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma
- Mina Sarah Ally, Sumaira Aasi, Ashley Wysong, Claudia Teng, Eric Anderson, Irene Bailey-Healy, Anthony Oro, Jinah Kim, Anne Lynn Chang, Jean Yuh Tang
- Leiomyosarcoma of the skin: Clinical, histopathologic, and prognostic factors that influence outcomes
- Daniel S. Winchester, Thomas L. Hocker, Jerry D. Brewer, Christian L. Baum, Philip C. Hochwalt, Christopher J. Arpey, Clark C. Otley, Randall K. Roenigk
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?